Congressman Brett Guthrie, Chairman of the House Committee on Energy and Commerce, said on Mar. 13 that the Environmental Protection Agency's (EPA) proposed amendment to a regulation affecting ethylene oxide (EtO) sterilization marks a significant policy shift. The EPA announced it would revise a Biden-Harris Administration rule that set stricter air emissions standards for EtO, which is used to sterilize medical equipment.
The issue is important because EtO is used to sterilize about half of all medical devices sold in the United States, including surgical instruments and syringes. For many devices sensitive to heat and moisture, there are currently no viable alternative methods for sterilization. Guthrie said the previous rule threatened to close sterilization facilities and disrupt supply chains for hospitals and providers.
“Today’s EPA announcement is a victory for commonsense policies that safeguard patients and put an end to the overreach of the Biden-Harris Administration,” said Guthrie. “The burdensome ethylene oxide rule threatened to shutter sterilization facilities and disrupt American medical supply chains that hospitals and providers rely on every day to safely treat patients. By proposing an amendment to this misguided regulation, EPA Administrator Zeldin is working under the authority that Congress provided under the Clean Air Act to help ensure the medical community maintains access to a safe and reliable domestic supply of sterilized medical devices used in millions of procedures each year, while continuing to protect human health and the environment.”
In 2023, witnesses at a hearing held by the Committee on Energy and Commerce Subcommittee on Environment, Manufacturing, & Critical Materials testified that the original proposal could significantly disrupt patient access to emergency care and increase risks from hospital-acquired infections.
The House Energy and Commerce Committee addresses legislation related to energy, health care, environmental protection, telecommunications, and consumer issues according to its official website. The committee has also influenced policy in areas such as energy innovation, broadband deployment, and pharmaceutical pricing according to its official website.
As one of the oldest standing committees in the U.S. House of Representatives according to its official website, it traces its origins back to 1795 when it was formed as the Committee on Commerce and Manufactures according to its official website.
Looking ahead, stakeholders will be watching how changes in federal regulations may affect both public health protections and continued access to essential medical supplies.
